|
1
|
Kashima T, Nakamura K, Kawaguchi J,
Takanashi M, Ishida T, Aburatani H, Kudo A, Fukayama M and
Grigoriadis AE: Overexpression of cadherins suppresses pulmonary
metastasis of osteosarcoma in vivo. Int J Cancer. 104:147–154.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bacci G, Rocca M, Salone M, Balladelli A,
Ferrari S, Palmerini E, Forni C and Briccoli A: High grade
osteosarcoma of the extremities with lung metastases at
presentation: Treatment with neoadjuvant chemotherapy and
simultaneous resection of primary and metastatic lesions. J Surg
Oncol. 98:415–420. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harting MT, Blakely ML, Jaffe N, Cox CS
Jr, Hayes-Jordan A, Benjamin RS, Raymond AK, Andrassy RJ and Lally
KP: Long-term survival after aggressive resection of pulmonary
metastases among children and adolescents with osteosarcoma. J
Pediatr Surg. 41:194–199. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsuchiya H, Kanazawa Y, Abdel-Wanis ME,
Asada N, Abe S, Isu K, Sugita T and Tomita K: Effect of timing of
pulmonary metastases identification on prognosis of patients with
osteosarcoma: The Japanese Musculoskeletal Oncology Group study. J
Clin Oncol. 20:3470–3477. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu PK, Chen WM, Chen CF, Lee OK, Haung CK
and Chen TH: Primary osteogenic sarcoma with pulmonary metastasis:
Clinical results and prognostic factors in 91 patients. Jpn J Clin
Oncol. 39:514–522. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tsuchiya H, Tomita K, Mori Y, Asada N and
Yamamoto N: Marginal excision for osteosarcoma with caffeine
assisted chemotherapy. Clin Orthop Relat Res. 358:27–35. 1999.
View Article : Google Scholar
|
|
8
|
Zanotti S and Canalis E: Notch signaling
and the skeleton. Endocr Rev. 37:223–253. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kofler NM, Shawber CJ, Kangsamaksin T,
Reed HO, Galatioto J and Kitajewski J: Notch signaling in
developmental and tumor angiogenesis. Genes Cancer. 2:1106–1116.
2011. View Article : Google Scholar
|
|
10
|
Engin F, Bertin T, Ma O, Jiang MM, Wang L,
Sutton RE, Donehower LA and Lee B: Notch signaling contributes to
the pathogenesis of human osteosarcomas. Hum Mol Genet.
18:1464–1470. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tanaka M, Setoguchi T, Hirotsu M, Gao H,
Sasaki H, Matsunoshita Y and Komiya S: Inhibition of Notch pathway
prevents osteosarcoma growth by cell cycle regulation. Br J Cancer.
100:1957–1965. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dailey DD, Anfinsen KP, Pfaff LE, Ehrhart
EJ, Charles JB, Bønsdorff TB, Thamm DH, Powers BE, Jonasdottir TJ
and Duval DL: HES1, a target of Notch signaling, is elevated in
canine osteosarcoma, but reduced in the most aggressive tumors. BMC
Vet Res. 9:1302013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Komori T: Regulation of osteoblast
differentiation by transcription factors. J Cell Biochem.
99:1233–1239. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hilton MJ, Tu X, Wu X, Bai S, Zhao H,
Kobayashi T, Kronenberg HM, Teitelbaum SL, Ross FP, Kopan R, et al:
Notch signaling maintains bone marrow mesenchymal progenitors by
suppressing osteoblast differentiation. Nat Med. 14:306–314. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McManus MM, Weiss KR and Hughes DP:
Understanding the role of Notch in osteosarcoma. Adv Exp Med Biol.
804:67–92. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Krishnan V, Bryant HU and Macdougald OA:
Regulation of bone mass by Wnt signaling. J Clin Invest.
116:1202–1209. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cai Y, Cai T and Chen Y: Wnt pathway in
osteosarcoma, from oncogenic to therapeutic. J Cell Biochem 1.
15:625–631. 2014. View Article : Google Scholar
|
|
18
|
Hoang BH, Kubo T, Healey JH, Sowers R,
Mazza B, Yang R, Huvos AG, Meyers PA and Gorlick R: Expression of
LDL receptor-related protein 5 (LRP5) as a novel marker for disease
progression in high-grade osteosarcoma. Int J Cancer. 109:106–111.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma Y, Ren Y, Han EQ, Li H, Chen D, Jacobs
JJ, Gitelis S, O'Keefe RJ, Konttinen YT, Yin G, et al: Inhibition
of the Wnt-β-catenin and Notch signaling pathways sensitizes
osteosarcoma cells to chemotherapy. Biochem Biophys Res Commun.
431:274–279. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mödder UI, Oursler MJ, Khosla S and Monroe
DG: Wnt10b activates the Wnt, notch, and NFκB pathways in U2OS
osteosarcoma cells. J Cell Biochem. 112:1392–1402. 2011. View Article : Google Scholar
|
|
21
|
Laplante M and Sabatini DM: mTOR signaling
in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu K, Dai HB and Qiu ZL: mTOR signaling in
osteosarcoma: Oncogenesis and therapeutic aspects (Review). Oncol
Rep. 36:1219–1225. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Perry JA, Kiezun A, Tonzi P, Van Allen EM,
Carter SL, Baca SC, Cowley GS, Bhatt AS, Rheinbay E, Pedamallu CS,
et al: Complementary genomic approaches highlight the PI3K/mTOR
pathway as a common vulnerability in osteosarcoma. Proc Natl Acad
Sci USA. 111:E5564–E5573. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Z, Gerstein M and Snyder M: RNA-Seq:
A revolutionary tool for transcriptomics. Nat Rev Genet. 10:57–63.
2009. View
Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Thompson S, Pearson AN, Ashley MD, Jessick
V, Murphy BM, Gafken P, Henshall DC, Morris KT, Simon RP and Meller
R: Identification of a novel Bcl-2-interacting mediator of cell
death (Bim) E3 ligase, tripartite motif-containing protein 2
(TRIM2), and its role in rapid ischemic tolerance-induced
neuroprotection. J Biol Chem. 286:19331–19339. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen X, Dong C, Law PT, Chan MT, Su Z,
Wang S, Wu WK and Xu H: MicroRNA-145 targets TRIM2 and exerts
tumor-suppressing functions in epithelial ovarian cancer. Gynecol
Oncol. 139:513–519. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Williams MD, Zhang L, Elliott DD, Perrier
ND, Lozano G, Clayman GL and El-Naggar AK: Differential gene
expression profiling of aggressive and nonaggressive follicular
carcinomas. Hum Pathol. 42:1213–1220. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Panaccione A, Guo Y, Yarbrough WG and
Ivanov SV: Expression profiling of clinical specimens supports the
existence of neural progenitor-like stem cells in basal breast
cancers. Clin Breast Cancer. 17:298–306.e7. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ivanov SV, Panaccione A, Nonaka D, Prasad
ML, Boyd KL, Brown B, Guo Y, Sewell A and Yarbrough WG: Diagnostic
SOX10 gene signatures in salivary adenoid cystic and breast
basal-like carcinomas. Br J Cancer. 109:444–451. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang K, Zhang G, Mei J, Chen D and Wu M:
Screening and analysis of pathogenic genes during DMBA-induced
buccal mucosa carcinogenesis in golden hamsters. Oncol Rep.
23:1619–1624. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Miyatake T, Ueda Y, Nakashima R, Yoshino
K, Kimura T, Murata T, Nomura T, Fujita M, Buzard GS and Enomoto T:
Down-regulation of insulin-like growth factor binding protein-5
(IGFBP-5): Novel marker for cervical carcinogenesis. Int J Cancer.
120:2068–2077. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Willis BC, Liebler JM, Luby-Phelps K,
Nicholson AG, Crandall ED, du Bois RM and Borok Z: Induction of
epithelial-mesenchymal transition in alveolar epithelial cells by
transforming growth factor-beta1: Potential role in idiopathic
pulmonary fibrosis. Am J Pathol. 166:1321–1332. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Willis BC and Borok Z: TGF-beta-induced
EMT: Mechanisms and implications for fibrotic lung disease. Am J
Physiol Lung Cell Mol Physiol. 293:L525–L534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Moses MA, Wiederschain D, Loughlin KR,
Zurakowski D, Lamb CC and Freeman MR: Increased incidence of matrix
metalloproteinases in urine of cancer patients. Cancer Res.
58:1395–1399. 1998.PubMed/NCBI
|
|
37
|
Finkel T, Deng CX and Mostoslavsky R:
Recent progress in the biology and physiology of sirtuins. Nature.
460:587–591. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Haigis MC and Guarente LP: Mammalian
sirtuins–emerging roles in physiology, aging, and calorie
restriction. Genes Dev. 20:2913–2921. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jeong SM, Xiao C, Finley LW, Lahusen T,
Souza AL, Pierce K, Li YH, Wang X, Laurent G, German NJ, et al:
SIRT4 has tumor-suppressive activity and regulates the cellular
metabolic response to DNA damage by inhibiting mitochondrial
glutamine metabolism. Cancer Cell. 23:450–463. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shi Q, Liu T, Zhang X, Geng J, He X, Nu M
and Pang D: Decreased sirtuin 4 expression is associated with poor
prognosis in patients with invasive breast cancer. Oncol Lett.
12:2606–2612. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Qi L and Ding Y: Involvement of the CREB5
regulatory network in colorectal cancer metastasis. Yi Chuan.
36:679–684. 2014.PubMed/NCBI
|
|
42
|
Harada Y, Tamura Y and Endo T:
Identification of yeast Art5 as a multicopy suppressor for the
mitochondrial translocator maintenance protein Tam41. Biochem
Biophys Res Commun. 392:228–233. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shih YL, Chou HM, Chou HC, Lu HF, Chu YL,
Shang HS and Chung JG: Casticin impairs cell migration and invasion
of mouse melanoma B16F10 cells via PI3K/AKT and NF-κB signaling
pathways. Environ Toxicol. 32:2097–2112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang J, Wang L, Ho CT, Zhang K, Liu Q and
Zhao H: Garcinol from Garcinia indica downregulates cancer
stem-like cell biomarker ALDH1A1 in nonsmall cell lung cancer A549
cells through DDIT3 activation. J Agric Food Chem. 65:3675–3683.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Čokić VP, Smith RD, Biancotto A, Noguchi
CT, Puri RK and Schechter AN: Globin gene expression in correlation
with G protein-related genes during erythroid differentiation. BMC
Genomics. 14:1162013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lian Z, Han J, Huang L, Wei C, Fan Y, Xu
J, Zhou M, Feng H, Liu Q, Chen L, et al: A005, a novel inhibitor of
phosphatidylinositol 3-kinase/mammalian target of rapamycin,
prevents osteosarcoma-induced osteolysis. Carcinogenesis. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yu G, Liu G, Yuan D, Dai J, Cui Y and Tang
X: Long non-coding RNA ANRIL is associated with a poor prognosis of
osteosarcoma and promotes tumorigenesis via PI3K/Akt pathway. J
Bone Oncol. 11:51–55. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen L, Pei H, Lu SJ, Liu ZJ, Yan L, Zhao
XM, Hu B and Lu HG: SPOP suppresses osteosarcoma invasion via
PI3K/AKT/NF-κB signaling pathway. Eur Rev Med Pharmacol Sci.
22:609–615. 2018.PubMed/NCBI
|
|
49
|
Hu B, Lv X, Gao F, Chen S, Wang S, Qing X,
Liu J, Wang B and Shao Z: Downregulation of DEPTOR inhibits the
proliferation, migration, and survival of osteosarcoma through
PI3K/Akt/mTOR pathway. OncoTargets Ther. 10:4379–4391. 2017.
View Article : Google Scholar
|
|
50
|
Pu Y, Yi Q, Zhao F, Wang H, Cai W and Cai
S: MiR-20a-5p represses multi-drug resistance in osteosarcoma by
targeting the KIF26B gene. Cancer Cell Int. 16:642016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fujimori A, Cheng SL, Avioli LV and
Civitelli R: Structure-function relationship of parathyroid
hormone: Activation of phospholipase-C, protein kinase-A and -C in
osteosarcoma cells. Endocrinology. 130:29–36. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Miles RR, Sluka JP, Halladay DL, Santerre
RF, Hale LV, Bloem L, Thirunavukkarasu K, Galvin RJ, Hock JM and
Onyia JE: ADAMTS-1: A cellular disintegrin and metalloprotease with
thrombospondin motifs is a target for parathyroid hormone in bone.
Endocrinology. 141:4533–4542. 2000. View Article : Google Scholar : PubMed/NCBI
|
